1. Home
  2. VALN vs PRLB Comparison

VALN vs PRLB Comparison

Compare VALN & PRLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VALN
  • PRLB
  • Stock Information
  • Founded
  • VALN 2012
  • PRLB 1999
  • Country
  • VALN France
  • PRLB United States
  • Employees
  • VALN N/A
  • PRLB N/A
  • Industry
  • VALN Biotechnology: Biological Products (No Diagnostic Substances)
  • PRLB Metal Fabrications
  • Sector
  • VALN Health Care
  • PRLB Industrials
  • Exchange
  • VALN Nasdaq
  • PRLB Nasdaq
  • Market Cap
  • VALN 777.9M
  • PRLB 928.0M
  • IPO Year
  • VALN 2021
  • PRLB 2012
  • Fundamental
  • Price
  • VALN $8.94
  • PRLB $49.32
  • Analyst Decision
  • VALN Strong Buy
  • PRLB Hold
  • Analyst Count
  • VALN 4
  • PRLB 3
  • Target Price
  • VALN $15.75
  • PRLB $43.50
  • AVG Volume (30 Days)
  • VALN 129.1K
  • PRLB 159.9K
  • Earning Date
  • VALN 11-06-2025
  • PRLB 10-31-2025
  • Dividend Yield
  • VALN N/A
  • PRLB N/A
  • EPS Growth
  • VALN N/A
  • PRLB N/A
  • EPS
  • VALN N/A
  • PRLB 0.61
  • Revenue
  • VALN $230,566,060.00
  • PRLB $508,637,000.00
  • Revenue This Year
  • VALN $15.55
  • PRLB $6.30
  • Revenue Next Year
  • VALN $23.93
  • PRLB $4.89
  • P/E Ratio
  • VALN N/A
  • PRLB $81.28
  • Revenue Growth
  • VALN 25.47
  • PRLB N/A
  • 52 Week Low
  • VALN $3.62
  • PRLB $26.35
  • 52 Week High
  • VALN $12.25
  • PRLB $51.09
  • Technical
  • Relative Strength Index (RSI)
  • VALN 49.28
  • PRLB 56.08
  • Support Level
  • VALN $8.33
  • PRLB $48.80
  • Resistance Level
  • VALN $9.46
  • PRLB $50.43
  • Average True Range (ATR)
  • VALN 0.35
  • PRLB 0.96
  • MACD
  • VALN -0.15
  • PRLB -0.36
  • Stochastic Oscillator
  • VALN 61.30
  • PRLB 30.80

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

About PRLB Proto Labs Inc. Common stock

Proto Labs Inc is an on-demand manufacturer of custom parts for prototyping and short-run production. The company offers developers and engineers quick-turn production services to reduce the time to market. Proto Labs uses injection molding, computer numerical control machining, and 3-D printing to manufacture custom parts for its clients. The company services clients' needs for prototype solutions, parts for testing procedures, bridge production capabilities during disruptions in manufacturing processes, limited-quantity requests, and end-of-life production support. Geographically, a majority of the company's revenue is derived from the United States and the rest from Europe.

Share on Social Networks: